Alzheimer's Frontline: New Brain Scan, Blood Thinner Potential, and Estrogen Link

The FDA has greenlit TAUKLARIFY, a new radioactive tracer for PET scans that highlights tau tangles in the brains of people being evaluated for Alzheimer's disease. This diagnostic tool, developed by Enigma Biomedical and Lantheus Holdings, gives doctors a clearer window into the pathology of the disease, which is critical for diagnosing Alzheimer's accurately and selecting patients for emerging therapies.

Zoom Out

The approval of TAUKLARIFY arrives amid a wave of new research...